SBI ALApharma Canada Inc. is a Toronto-based medical imaging company. We are currently expanding the clinical translation and applications of our proprietary handheld EagleTM imaging technology.
We aim to use our EagleTM fluorescence imaging device alongside the fluorescence contrast prodrug 5-Aminolevulinic Acid (5-ALA). We hope to improve the detection and resection of breast tumor cells intraoperatively - in real time - during index breast conserving surgery.
Established in August 2019, SBI ALApharma Canada Inc. is a wholly-owned subsidiary of Photonamic GmbH & Co. KG in Pinneberg, Germany (PHN).